C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2006
12/13/2006	EP1730100A1 Polyamine analogs that activate antizyme frameshifting
12/13/2006	EP1730099A2 Mitotic kinesin inhibitors
12/13/2006	EP1729756A2 Novel pharmaceutical compositions
12/13/2006	EP1483241A4 Cyclic derivatives as modulators of chemokine receptor activity
12/13/2006	EP1420788B1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
12/13/2006	EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
12/13/2006	CN1878551A 4-phenyl piperdine sulfonyl glycine transporter inhibitors
12/13/2006	CN1289496C Process for producing novel paroxetine hydrochloride anhydrate
12/13/2006	CN1289482C Organic acid salt of amlodipine
12/13/2006	CN1289481C Biphenylcarboxamides useful as lipid lowering agents
12/13/2006	CN1289480C Process for chiral synthesis of (2S,6R)-2,6-dialkyl piperidine hydrochloride
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289451C Di-ether used in preparation of Ziegler-Natta catalyst
12/12/2006	US7148358 Process for the preparation of S(−) amlodipine-L(+)-hemi taratarte
12/12/2006	US7148355 Process for the preparation of repaglinide
12/12/2006	US7148354 Process for preparation of donepezil
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148251 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/12/2006	US7148244 Medicines in controlling Vpr function
12/12/2006	US7148238 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]piperidine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder.
12/12/2006	US7148198 Antibacterial agents
12/07/2006	WO2006130075A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006	WO2006129826A1 Novel piperidine derivative
12/07/2006	WO2006128803A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
12/07/2006	WO2006057977A3 Cycloalkyl piperidine tachykinin receptor antagonists
12/07/2006	WO2006044362A3 N-sulfonylpiperidine cannabinoid receptor 1 antagonists
12/07/2006	WO2006014012A3 Aromatic compounds
12/07/2006	US20060276654 Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom
12/07/2006	US20060276642 Compounds to treat Alzheimer's disease
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276508 Amide derivatives as somatostatin receptor 5 antagonists
12/07/2006	US20060276507 Hydroxamate sulfonamides as cd23 shedding inhibitors
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276467 Sodium channel modulators
12/07/2006	US20060276433 Hydrazone derivative
12/07/2006	US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors
12/07/2006	CA2610671A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006	CA2609388A1 Novel piperidine derivative
12/07/2006	CA2608819A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
12/07/2006	CA2608212A1 Novel piperidine carboxylic acid amide derivatives
12/06/2006	EP1728784A1 Fluorene derivative
12/06/2006	EP1727794A1 Novel benzyl(idene)-lactam derivatives
12/06/2006	EP1727782A1 Method of producing aminophenol compounds
12/06/2006	EP1572668A4 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
12/06/2006	EP1505066B1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic
12/06/2006	EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/06/2006	CN1874999A Industrial method for separation and purification of fentanyl by reverse phase preparative chromatography
12/06/2006	CN1874998A 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl]-methyl piperidine oxalate (donepezil oxalate) and its polymorphs
12/06/2006	CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof
12/06/2006	CN1874777A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/06/2006	CN1874775A 4-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (VR1) for the treatment of pain
12/06/2006	CN1288135C Certain 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor XA
12/06/2006	CN1288134C Antibacterial mutilins
12/05/2006	US7145039 Transfection reagents
12/05/2006	US7145035 Using palladium alkylation catalyst
12/05/2006	US7145010 Tert-alkylphenoxy-substituted polycyclic compounds
12/05/2006	US7144920 asymmetrically-substituted xylylenediamines, e.g., N-(3-aminopropyl)-xylylenediamine; cancer, mucositis, asthma, inflammation, autoimmune disease, psoriasis, restentosis, rheumatoid arthritis, scleroderma, lupus, diabetes, tissue transplantation, osteoporosis, hyperparathyroidism, peptic ulcers, glaucoma
12/05/2006	US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006	US7144884 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder.
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006	US7144881 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders
12/05/2006	US7144691 Oxiranylmethoxyhydrocarbyl-N-oxypiperidine derivatives as stabilizers; blue sensitive silver halide emulsion layer yellow coupler, green sensitive layer contains magenta coupler, and red sensitive layer contains cyan coupler; storage stability
11/2006
11/30/2006	WO2006127184A1 Process for preparation of sulfamide derivatives
11/30/2006	WO2006126948A1 Piperidines for the treatment of chemokine mediated diseases
11/30/2006	WO2006126947A1 Piperidines for the treatment of chemokine mediated diseases
11/30/2006	WO2006126676A1 Cyclic amine derivative having substituted alkyl group
11/30/2006	WO2006125397A1 Nonsteroic androgen acceptor regulators, preparation process, pharmaceutical composition and use thereof
11/30/2006	WO2006109075A3 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
11/30/2006	WO2006099301A3 Apoptosis inhibitors
11/30/2006	US20060270855 Methods of preparing retroviral proteases inhibitor intermediates
11/30/2006	US20060270847 Process for producing nitrogenous heterocyclic compound
11/30/2006	US20060270715 Dosage forms of amlodipine and processes for their preparation
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	CA2609852A1 Cyclic amine derivative having substituted alkyl group
11/30/2006	CA2609185A1 Process for preparation of sulfamide derivatives
11/29/2006	EP1726952A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725535A2 Hiv integrase inhibitors
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725235A1 Piperidine derivatives useful as ccr3 antagonists
11/29/2006	EP1572207A4 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
11/29/2006	EP1117801B1 Polyketide synthase enzymes and recombinant dna constructs therefor, for the production of compounds related to fk-506 and fk-520
11/29/2006	EP1076053B1 3-arylphenyl sulfide derivatives and insecticides and miticides
11/29/2006	CN1871225A Preferentially substituted calcium channel blockers
11/29/2006	CN1286831C N-ureido-piperidines as antagonists viii for CCR-3 receptor
11/29/2006	CN1286812C Bispiperidines as antithrombotic agents
11/28/2006	US7141674 Anti-inflammatory compounds
11/28/2006	US7141673 ozonation of 2-methyl-5-vinylpyridine, then reducing to 2-methylpyridine-5-carbaldehyde, which is reacted with dialkylamines and cyano compounds to give N,N dialkylamino-(6-methyl-3-pyridyl)-acetonitrile, and then with 4-(methylsulfonyl)benzyl halide to form intermediates of COX-2 inhibitors
11/28/2006	US7141671 Biphenyl derivatives
11/28/2006	US7141590 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
11/28/2006	US7141582 Promoting the activity of glucocerebrosidease by administering a reversible competitive inhibitor such as iminosugars, e.g. calysegnines, isofagomines,N-alkyl-deoxynojirimycins; lysosomal storage disorders
11/28/2006	US7141573 Huntington's diseases, Alzheimer's diseases, psychological disorders
11/28/2006	US7141568 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/28/2006	US7141560 For use as analgesic or sedative; treating sleep disorders
11/28/2006	CA2239138C Process for preparation of a salt of .gamma.-(piperidyl) butyric acid with an acid
11/28/2006	CA2160444C Aroyl-piperdine derivatives
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006123244A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors

1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 380